Replies to post #124153 on Biotech Values

[ghmm]

AMGN / LGND / Nplate:

Sales of Nplate® (romiplostim) increased 28 percent to $77 million in the third quarter of 2011 versus $60 million in the third quarter of 2010. These increases were driven primarily by global demand.


http://wwwext.amgen.com/media/media_pr_detail.jsp?releaseID=1620695